Search hospitals

>

Montana

>

Butte

Saint James Community Hospital and Cancer Treatment Center

Claim this profile

Butte, Montana 59701

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Breast cancer

Conducts research for Lymphoma

Conducts research for Leukemia

356 reported clinical trials

9 medical researchers

Photo of Saint James Community Hospital and Cancer Treatment Center in ButtePhoto of Saint James Community Hospital and Cancer Treatment Center in Butte

Summary

Saint James Community Hospital and Cancer Treatment Center is a medical facility located in Butte, Montana. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Lymphoma, Leukemia and other specialties. Saint James Community Hospital and Cancer Treatment Center is involved with conducting 356 clinical trials across 422 conditions. There are 9 research doctors associated with this hospital, such as Nicholas DiBella, Benjamin J. George, Marwan Massouh, and Karng S. Log.

Area of expertise

1

Breast Cancer

Global Leader

Saint James Community Hospital and Cancer Treatment Center has run 68 trials for Breast Cancer. Some of their research focus areas include:

ER positive
HER2 negative
Stage IV
2

Lung Cancer

Global Leader

Saint James Community Hospital and Cancer Treatment Center has run 54 trials for Lung Cancer. Some of their research focus areas include:

Stage II
Stage I
Stage IV

Top PIs

Clinical Trials running at Saint James Community Hospital and Cancer Treatment Center

Ovarian Cancer

Breast Cancer

Lung Cancer

Prostate Cancer

Esophageal cancer

Small Cell Lung Cancer

Breast cancer

Esophageal Cancer

Stomach Cancer

Non-Small Cell Lung Cancer

Image of trial facility.

Olaparib +/- Bevacizumab

for Ovarian Cancer

This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.

Recruiting

2 awards

Phase 3

4 criteria

Image of trial facility.

Biobank Collection

for Cancer

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

Recruiting

1 award

N/A

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Saint James Community Hospital and Cancer Treatment Center?

Where is Saint James Community Hospital and Cancer Treatment Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Saint James Community Hospital and Cancer Treatment Center accept?

What awards or recognition has Saint James Community Hospital and Cancer Treatment Center received?